Social health insurance and drug spending among cancer inpatients in China

Health Affairs

Volumn 27, Issue 4, 2008, Pages 1020-1027

  Zhou, Bo ^a   Yang, Li ^a   Sun, Qingmin ^a   Gu, Haijuan ^a   Wang, Bin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER PATIENT; CHINA; DRUG COST; GOVERNMENT REGULATION; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEALTH PROGRAM; HOSPITAL PATIENT; PATIENT SELECTION; PUBLIC HEALTH SERVICE; REIMBURSEMENT;

AGED; CHINA; DRUG COSTS; DRUG UTILIZATION; FEMALE; HEALTH EXPENDITURES; HOSPITAL CHARGES; HOSPITALS, UNIVERSITY; HUMANS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; NEOPLASMS; PHARMACEUTICAL PREPARATIONS; REGRESSION ANALYSIS;

EID: 48149108932     PISSN: 02782715     EISSN: 02782715     Source Type: Journal    
DOI: 10.1377/hlthaff.27.4.1020     Document Type: Article

References (17)

1. H. Zhu et al., "Myeloperoxidase G-463A Polymorphism and the Risk of Gastric Cancer: A Case-Control Study," Carcinogenesis 27, no. 12 (2006): 2491-2496.
2. L.S.Ho, "Market Reforms and China's Health Care System," Social Science and Medicine 41, no. 8 (1995): 1065-1072.
3. W.C. Hsiao, "The Chinese Health Care System: Lessons for Other Nations," Social Science and Medicine 41, no. 8 (1995): 1047-1055.
4. Y. Liu, "Reforming China's Urban Health Insurance System," Health Policy 60, no. 2 (2002): 133-150.
5. Y. Liu, W.C. Hsiao, and K. Eggleston, "Equity in Health and Health Care: The Chinese Experience," Social Science and Medicine 49, no. 10 (1999): 1349-1356.
6. Q. Meng et al., "The Impact of China's Retail Drug Price Control Policy onHospital Expenditures: A Case Study in Two Shandong Hospitals," Health Policy and Planning 20, no. 3 (2005): 185-196.
7. J. Gao et al., "Changing Access to Health Services in Urban China: Implications for Equity," Health Policy and Planning 16, no. 3 (2001): 302-312.
8. M. Wu et al., "Private and Public Cross-Subsidization: Financing Beijing's Health-Insurance Reform," Health Policy 72, no. 1 (2005): 41-52.
9. K. Eggleston and W. Yip, "Hospital Competition under Regulated Prices: Application to Urban Health Sector Reforms in China," International Journal of Health Care Finance and Economics 4, no. 4 (2004): 343-368.
10. J. Doherty et al., "What Is Next for Pharmacoeconomics and Outcomes Research in Asia?" Value in Health 7, no. 2 (2004): 118-132.
11. See, for example, X. Xu et al., "Insurance Coverage and Health Care Use among Near-Elderly Women," Women's Health Issues 16, no. 3 (2006): 139-148.
12. H. Dong et al., "A Description of Outpatient Drug Use in Rural China: Evidence of Differences Due to Insurance Coverage," International Journal of Health Planning and Management 14, no. 1 (1999): 41-56.
13. F. Tu et al., "Analysis of Hospital Charges for Cerebral Infarction Stroke Inpatients in Beijing, People's Republic of China," Health Policy 59, no. 3 (2002): 243-256.
14. X. Liu and A. Mills, "Financing Reforms of Public Health Services in China: Lessons for Other Nations," Social Science and Medicine 54, no. 11 (2002): 1691-1698.
15. T. Hesketh and X.Z. Wei, "Health in China: From Mao to Market Reform," British Medical Journal 314, no. 7093 (1997): 1543-1545.
16. M. Danis et al., "How Does Lack of Insurance Affect Use of Intensive Care? A Population-Based Study," Critical Care Medicine 34, no. 8 (2006): 2043-2048.
17. See, for example, T. Reed et al., "System to Decrease Length of Stay for Vascular Surgery," Journal of Vascular Surgery 39, no. 2 (2004): 395-399.